Search Results - "Quintero, Marisol"
-
1
Ki67 Changes Identify Worse Outcomes in Residual Breast Cancer Tumors After Neoadjuvant Chemotherapy
Published in The oncologist (Dayton, Ohio) (01-06-2018)“…Background Several breast cancer (BC) trials have adopted pathological complete response (pCR) as a surrogate marker of long‐term treatment efficacy. In…”
Get full text
Journal Article -
2
Mitochondria as Signaling Organelles in the Vascular Endothelium
Published in Proceedings of the National Academy of Sciences - PNAS (04-04-2006)“…Vascular endothelial cells are highly glycolytic and consume relatively low amounts of oxygen (O₂) compared with other cells. We have confirmed that oxidative…”
Get full text
Journal Article -
3
Immunotherapeutic effects of intratumoral nanoplexed poly I:C
Published in Journal for immunotherapy of cancer (02-05-2019)“…Poly I:C is a powerful immune adjuvant as a result of its agonist activities on TLR-3, MDA5 and RIG-I. BO-112 is a nanoplexed formulation of Poly I:C complexed…”
Get full text
Journal Article -
4
Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production
Published in Proceedings of the National Academy of Sciences - PNAS (10-04-2007)“…An increased dependency on glycolysis for ATP production is considered to be a hallmark of tumor cells. Whether this increase in glycolytic activity is due…”
Get full text
Journal Article -
5
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic
Published in Oncoimmunology (2023)“…BO-112 is a poly I:C-based viral mimetic that exerts anti-tumor efficacy when intratumorally delivered in mouse models. Intratumoral BO-112 synergizes in mice…”
Get full text
Journal Article -
6
Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy
Published in Journal for immunotherapy of cancer (01-11-2021)“…BackgroundBO-112 is a nanoplexed form of polyinosinic:polycytidylic acid that acting on toll-like receptor 3 (TLR3), melanoma differentiation-associated…”
Get full text
Journal Article -
7
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C
Published in Journal for immunotherapy of cancer (16-04-2024)“…BackgroundLymphocytic choriomeningitis virus (LCMV) belongs to the Arenavirus family known for inducing strong cytotoxic T-cell responses in both mice and…”
Get full text
Journal Article -
8
Endogenous NO Regulates Superoxide Production at Low Oxygen Concentrations by Modifying the Redox State of Cytochrome c Oxidase
Published in Proceedings of the National Academy of Sciences - PNAS (18-05-2004)“…We have investigated in whole cells whether, at low oxygen concentrations ([ O2]), endogenous nitric oxide (NO) modulates the redox state of the mitochondrial…”
Get full text
Journal Article -
9
Inhibition of Mitochondrial Respiration by Endogenous Nitric Oxide: A Critical Step in Fas Signaling
Published in Proceedings of the National Academy of Sciences - PNAS (25-06-2002)“…We have found that activation of human adult T cell leukemia (Jurkat) cells with anti-Fas Ab leads, in a concentration-dependent manner, to an early burst of…”
Get full text
Journal Article -
10
Inhibition of mitochondrial respiration by the anticancer agent 2-methoxyestradiol
Published in Biochemical and biophysical research communications (24-09-2004)“…2-Methoxyestradiol (2ME2), a naturally occurring metabolite of estradiol, is known to have antiproliferative, antiangiogenic, and proapoptotic activity…”
Get full text
Journal Article -
11
Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma
Published in Science translational medicine (14-10-2020)“…Defects in tumor-intrinsic interferon (IFN) signaling result in failure of immune checkpoint blockade (ICB) against cancer, but these tumors may still maintain…”
Get more information
Journal Article -
12
Abstract 1790: BO-112 as a modifier of the tumor microenvironment for liver metastases
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Introduction: BO-112 is an analogue of double-stranded viral RNA which is an agonist of TLR3, RIG-1 and MDA5. It is currently in phase II clinical…”
Get full text
Journal Article -
13
Abstract CT221: A phase I study of intratumoral BO-112 and nivolumab for resectable soft tissue sarcoma
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: BO-112 is a double stranded synthetic RNA formulated with polyethyleneimine. By mimicking a viral infection, it mobilizes the immune…”
Get full text
Journal Article -
14
Abstract CT192: Phase IIa open-label clinical study of intratumoural administration of BO-112 in combination with pembrolizumab in subjects with liver metastasis from colorectal cancer or gastric/gastro-oesophageal junction cancer
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Protocol tittle: Study of BO-112 with pembrolizumab for colorectal or gastric/GEJ cancer with liver metastasis.Background: Gastric (GC),…”
Get full text
Journal Article -
15
Abstract CT233: Phase 2 clinical study to evaluate the efficacy and safety of intratumoral BO-112 in combination with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Background: BO-112 is a double stranded synthetic RNA formulated with polyethyleneimine (PEI), that acts as an agonist to toll-like receptor 3 and…”
Get full text
Journal Article -
16
Combination of radiomic and biomarker signatures as exploratory objective in a phase II trial with intratumoral BO-112 plus pembrolizumab for advanced melanoma
Published in Journal of clinical oncology (20-05-2021)“…Abstract only TPS9586 Background: Intratumoral immunotherapies are gaining interest in oncology, particularly in melanoma. These therapies, however, have faced…”
Get full text
Journal Article -
17
Abstract 3446: Radiation and intratumoral activation of double-stranded RNA sensors redirects myeloid cells and primes adaptive immunity
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Background: Undifferentiated pleomorphic sarcoma (UPS) is a common aggressive sarcoma subtype for which existing therapies are ineffective. Immune…”
Get full text
Journal Article -
18
Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
Published in Journal for immunotherapy of cancer (01-01-2023)“…Radioimmunotherapy combines irradiation of tumor lesions with immunotherapy to achieve local and abscopal control of cancer. Most immunotherapy agents are…”
Get full text
Journal Article -
19
Abstract 6216: Intratumoral B0112 in combination with radiotherapy synergizes to achieve CD8 T cell mediated local tumor control
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Background: Radioimmunotherapy combines irradiation of tumor lesions with immunotherapy to achieve local and abscopal control of cancer. Most…”
Get full text
Journal Article -
20
Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1α in cancer : Role of free radical formation
Published in Cancer research (Chicago, Ill.) (15-01-2006)“…Abstract Widespread expression of the α-subunit of hypoxia-inducible factor (HIF-1α) was observed in samples of human oral squamous cell carcinoma. In all the…”
Get full text
Journal Article